Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies.
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.
Age-related and cuprizone-induced changes in myelin and transcription factor gene expression and in oligodendrocyte cell densities in the rostral corpus callosum of mice.
Glial Biology: Functional Interactions Among Glia & Neurons (Gordon Research Seminar)
Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial
Multiple sclerosis, vitamin D, and HLA-DRB1*15.
Avonex approval application
Neuroscience 2014
Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice.
Teva announces U.S. FDA approval of three-times-a-week COPAXONE® (glatiramer acetate injection) 40mg/mL
Delta-9-tetrahydrocannabinol/cannabidiol (sativex(®)): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis.
Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence.
MSGene
Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity.
Second International Porto Congress of Multiple Sclerosis
American Academy of Neurology 2012 Annual Meeting
Glia in Health & Disease
A study comparing the effectiveness and safety of teriflunomide and interferon beta-1a in patients with relapsing multiple sclerosis (TENERE)
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.
Understanding the Metabolic Consequences of Human Arylsulfatase A Deficiency through a Computational Systems Biology Study.
Headaches in multiple sclerosis: Cross-sectional study of a multiethnic population.
“Veterinary Medicines” page
UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model.
Estrogen and testosterone therapies in multiple sclerosis.
Biogen Idec's TECFIDERA™ (dimethyl fumarate) approved in US as a first-line oral treatment for multiple sclerosis

Pages